|
AGPS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77210024432384E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78900000036286E-07 |
| Normal-vs-Stage2 |
1.053740E-02 |
| Normal-vs-Stage3 |
2.289600E-02 |
| Normal-vs-Stage4 |
3.356200E-02 |
| Stage1-vs-Stage2 |
9.188200E-01 |
| Stage1-vs-Stage3 |
7.998800E-01 |
| Stage1-vs-Stage4 |
1.702400E-02 |
| Stage2-vs-Stage3 |
8.971800E-01 |
| Stage2-vs-Stage4 |
1.424990E-01 |
| Stage3-vs-Stage4 |
1.730580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.67879965274187E-10 |
| Normal-vs-AfricanAmerican |
3.172300E-04 |
| Normal-vs-Asian |
5.627200E-01 |
| Caucasian-vs-AfricanAmerican |
3.880400E-02 |
| Caucasian-vs-Asian |
3.137200E-01 |
| AfricanAmerican-vs-Asian |
4.373800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.49320000200726E-08 |
| Normal-vs-Female |
9.61310000047177E-07 |
| Male-vs-Female |
6.166400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.257500E-02 |
| Normal-vs-Extreme_Weight |
2.775300E-04 |
| Normal-vs-Obese |
2.2377999999712E-06 |
| Normal-vs-Extreme_Obese |
1.075640E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.136800E-01 |
| Normal_Weight-vs-Obese |
1.191000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.253800E-01 |
| Extreme_Weight-vs-Obese |
2.716000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.793000E-01 |
| Obese-vs-Extreme_Obese |
6.767400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.964800E-03 |
| Normal-vs-Age(41-60Yrs) |
7.74309949491681E-10 |
| Normal-vs-Age(61-80Yrs) |
1.60838999999635E-05 |
| Normal-vs-Age(81-100Yrs) |
3.092400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.281600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.562400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.079200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.519200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.648800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.862800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.26219084867807E-12 |
| Normal-VS-Type2 PRCC |
4.299100E-03 |
| Normal-VS-KIRP CIMP |
2.302000E-01 |
| Normal-VS-Unclassified PRCC |
3.084900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.737900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.485580E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.345800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.725600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.220400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.471160E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.484600E-03 |
| Normal-vs-N1 |
4.964200E-02 |
| Normal-vs-N2 |
7.556000E-01 |
| N0-vs-N1 |
8.444800E-01 |
| N0-vs-N2 |
4.080000E-01 |
| N1-vs-N2 |
4.604400E-01 |
|
|
